In order to investigate the contribution of kinin receptor antagonism
in the treatment of LPS-induced shock we conducted a randomized study
with anaesthetized piglets. Before randomization the animals were stra
tified according to predetermined health criteria under baseline condi
tions. One group of control animals received LPS from S. abortus equi
(2 mu g/kg/h.i.v. for 8 h) and saline (Group 1). Another group receive
d LPS and the B-2 antagonist CP-0127 (3 mu g/kg/min), beginning 1 h af
ter LPS (Group 2). Group 3 received LPS and the B-2 antagonist in the
aforementioned doses, and the B-1 antagonist io Leu(9)-des-Arg(10)-kal
lidin (3 mu g/kg/min), also beginning 1 h after LPS. Overall survival
figures after 8 h of LPS infusion were: Group 1, 10/22 (45%); Group 2,
10/17 (59%); Group 3, 10/28 (36%). Fifty percent (29/58) of animals t
hat were healthy at baseline survived, but only 11% (1/9) of sick anim
als survived (Log Rank p = 0.0001). In the subset of healthy animals,
survival rates for Groups 2 and 3 were 77% and 38%, respectively (p =
0.0519). It appears, therefore, that B-2 blockade attenuates LPS-induc
ed mortality whereas additional B-1 blockade seems to reverse these be
neficial effects. This suggests that in this animal model the B-1 rece
ptor does not serve the same purpose as the B-2 receptor, and that up-
regulation of B-1 receptors during LPS shock may be an important mecha
nism of host defence.